AP

Alnylam Pharmaceuticals

ALNY
NASDAQHealth Care

Recent Patents

alny
1 year ago

Filed a patent for "compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression" on Thu, February 27, 2025

New US Patent
alny
1 year ago

Filed a patent for "rna interference mediated inhibition of prolyl hydroxylase domain 2 (phd2) gene expression using short interfering nucleic acid (sina)" on Thu, February 27, 2025

New US Patent
alny
1 year ago

Filed a patent for "methods and compositions for treating ctnnb1-associated disorders" on Fri, August 4, 2023

New US Patent
alny
1 year ago

Filed a patent for "aminoadipate-semialdehyde synthase (aass) irna compositions and methods of use thereof" on Fri, August 4, 2023

New US Patent
alny
1 year ago

Filed a patent for "serpina1 irna compositions and methods of use thereof" on Mon, June 26, 2023

New US Patent
alny
1 year ago

Filed a patent for "3-hydroxy-3-methylglutaryl-coa reductase (hmgcr) irna compositions and methods of use thereof" on Thu, February 6, 2025

New US Patent
alny
1 year ago

Filed a patent for "inhibin subunit beta e (inhbe) modulator compositions and methods of use thereof" on Thu, February 13, 2025

New US Patent
alny
1 year ago

Filed a patent for "serpina1 irna compositions and methods of use thereof" on Thu, February 6, 2025

New US Patent
alny
1 year ago

Filed a patent for "apolipoprotein c3 (apoc3) irna compositions and methods of use thereof" on Thu, February 13, 2025

New US Patent
alny
1 year ago

Filed a patent for "compositions and methods for inhibiting expression of the alas1 gene" on Thu, January 30, 2025

New US Patent
alny
1 year ago

Filed a patent for "sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof" on Thu, January 30, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "complement factor b (cfb) irna compositions and methods of use thereof" on Thu, January 23, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "irna compositions and methods for silencing angptl4" on Wed, March 13, 2024

New US Patent
alny
over 1 year ago

Filed a patent for "irna compositions and methods for silencing complement component 3 (c3)" on Thu, January 16, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "compositions and methods for inhibiting expression of the lect2 gene" on Thu, January 16, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "lactate dehydrogenase a (ldha) irna compositions and methods of use thereof" on Thu, January 16, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "huntingtin (htt) irna agent compositions and methods of use thereof" on Thu, January 9, 2025

New US Patent
alny
over 1 year ago

Filed a patent for "modified oligonucleotides and double-stranded rnas" on Thu, June 15, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "kisspeptin 1 (kiss1) irna compositions and methods of use thereof" on Thu, December 26, 2024

New US Patent
alny
over 1 year ago

Filed a patent for "six membered ring containing oligomers" on Wed, February 1, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "reversir molecules and methods of use thereof" on Thu, February 9, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "formulations for irna agent delivery" on Wed, April 12, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "extrahepatic delivery" on Wed, April 12, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "amyloid precursor protein (app) rnai agent compositions and methods of use thereof" on Tue, April 25, 2023

New US Patent
alny
over 1 year ago

Filed a patent for "amyloid precursor protein (app) rnai agent compositions and methods of use thereof" on Thu, May 4, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...